Argitalpenak (50) MARÍA DE LA ALMUDENA GÓMEZ HERNÁNDEZ argitalpenak

2024

  1. Dysregulation of micro-RNA 143-3p as a Biomarker of Carotid Atherosclerosis and the Associated Immune Reactions During Disease Progression

    Journal of Cardiovascular Translational Research

2023

  1. Increased let-7d-5p in non-alcoholic fatty liver promotes insulin resistance and is a potential blood biomarker for diagnosis

    Liver International, Vol. 43, Núm. 8, pp. 1714-1728

  2. Oxidative Stress Modulation by ncRNAs and Their Emerging Role as Therapeutic Targets in Atherosclerosis and Non-Alcoholic Fatty Liver Disease

    Antioxidants, Vol. 12, Núm. 2

  3. Syndecan-4 proteoliposomes enhance revascularization in a rabbit hind limb ischemia model of peripheral ischemia

    Acta Biomaterialia, Vol. 167, pp. 425-435

2022

  1. Implication of miR-155-5p and miR-143-3p in the Vascular Insulin Resistance and Instability of Human and Experimental Atherosclerotic Plaque

    International journal of molecular sciences, Vol. 23, Núm. 18

  2. Rhamnan sulfate reduces atherosclerotic plaque formation and vascular inflammation

    Biomaterials, Vol. 291

2021

  1. Concerted regulation of non-alcoholic fatty liver disease progression by microRNAs in apolipoprotein E-deficient mice

    DMM Disease Models and Mechanisms, Vol. 14, Núm. 12

  2. Severe Hepatic Insulin Resistance Induces Vascular Dysfunction: Improvement by Liver-Specific Insulin Receptor Isoform A Gene Therapy in a Murine Diabetic Model

    Cells, Vol. 10, Núm. 8

2020

  1. Specific knockout of p85α in brown adipose tissue induces resistance to high-fat diet–induced obesity and its metabolic complications in male mice

    Molecular Metabolism, Vol. 31, pp. 1-13

  2. The interplay between oxidative stress and miRNAs in obesity-associated hepatic and vascular complications

    Antioxidants, Vol. 9, Núm. 7, pp. 1-18

  3. miRNA Dysregulation in the Development of Non-Alcoholic Fatty Liver Disease and the Related Disorders Type 2 Diabetes Mellitus and Cardiovascular Disease

    Frontiers in Medicine, Vol. 7

2019

  1. Liver-specific insulin receptor isoform A expression enhances hepatic glucose uptake and ameliorates liver steatosis in a mouse model of diet-induced obesity

    DMM Disease Models and Mechanisms, Vol. 12, Núm. 2

2018

  1. Chronic exercise improves mitochondrial function and insulin sensitivity in brown adipose tissue

    Frontiers in Physiology, Vol. 9, Núm. AUG

  2. Potential role of insulin receptor isoforms and IGF receptors in plaque instability of human and experimental atherosclerosis

    Cardiovascular Diabetology, Vol. 17, Núm. 1

2017

  1. The Role of Insulin Receptor Isoforms in Diabetes and Its Metabolic and Vascular Complications

    Journal of Diabetes Research, Vol. 2017

2016

  1. Differential Role of Adipose Tissues in Obesity and Related Metabolic and Vascular Complications

    International Journal of Endocrinology, Vol. 2016

  2. Expression of insulin receptor (IR) A and B isoforms, IGF-IR, and IR/IGF-IR hybrid receptors in vascular smooth muscle cells and their role in cell migration in atherosclerosis

    Cardiovascular Diabetology, Vol. 15, Núm. 1

  3. Insulin receptor isoform A ameliorates long-term glucose intolerance in diabetic mice

    DMM Disease Models and Mechanisms, Vol. 9, Núm. 11, pp. 1271-1281

  4. Papel de la isoforma A del receptor de la insulina y del IGF-1R en el crecimiento de la placa aterosclerótica

    Anales de la Real Academia Nacional de Farmacia, Vol. 82, Núm. 2, pp. 129-142

  5. Papel de la isoforma A del receptor de la insulina y del IGF-1R en el crecimiento de la placa aterosclerótica

    Anales de la Real Academia Nacional de Farmacia, Vol. 82, Núm. 2, pp. 129-142